When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions The Unregulated World of Peptides: A Legal Minefield for Providers Holt Law FDA Puts BPC 157, TB 500, and 5 Other Peptides Under the Microscope: What Prescribers Need to Know About the 503A Review Lengea In a major policy shift, the U.S. Food and Drug Administration is reconsidering restrictions on several controversial peptides, including trending compounds like BPC 157 and Melanotan II. The move comes as demand for